BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10629562)

  • 1. Value of morphometry, texture analysis, densitometry, and histometry in the differential diagnosis and prognosis of malignant mesothelioma.
    Weyn B; Van De Wouwer G; Koprowski M; Van Daele A; Dhaene K; Scheunders P; Jacob W; Van Marck E
    J Pathol; 1999 Dec; 189(4):581-9. PubMed ID: 10629562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Malignant mesothelioma of the pleura. Morphometric study].
    Serio G; Caniglia DM; Pennella A; Giardina C; Dalena AM; Serio R; Lettini T; Ricco R
    Pathologica; 1997 Apr; 89(2):122-7. PubMed ID: 9411357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of morphometric methods in cytologic diagnostics: differentiation between mesothelial cells, mesothelioma cells and metastatic adenocarcinoma cells in pleural effusions with special emphasis on chromatin texture.
    Oberholzer M; Ettlin R; Christen H; Gschwind R; Buser M; Rösel F; Lötscher R; Dalquen P
    Anal Cell Pathol; 1991 Jan; 3(1):25-42. PubMed ID: 2001333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of tumour angiogenesis as a prognostic marker in malignant mesothelioma.
    Kumar-Singh S; Vermeulen PB; Weyler J; Segers K; Weyn B; Van Daele A; Dirix LY; Van Oosterom AT; Van Marck E
    J Pathol; 1997 Jun; 182(2):211-6. PubMed ID: 9274533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of GATA-6 transcription factor in pleural malignant mesothelioma and metastatic pulmonary adenocarcinoma.
    Lindholm PM; Soini Y; Myllärniemi M; Knuutila S; Heikinheimo M; Kinnula VL; Salmenkivi K
    J Clin Pathol; 2009 Apr; 62(4):339-44. PubMed ID: 19060016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A morphometrically-based classification rule for the diagnosis of primary mesothelial lesions.
    Robutti F; Betta PG; Donna A; Pavesi M
    J Pathol; 1990 Sep; 162(1):57-60. PubMed ID: 2231194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-assisted differential diagnosis of malignant mesothelioma based on syntactic structure analysis.
    Weyn B; van de Wouwer G; Kumar-Singh S; van Daele A; Scheunders P; van Marck E; Jacob W
    Cytometry; 1999 Jan; 35(1):23-9. PubMed ID: 10554177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis of malignant and reactive cells from serous effusions: image and texture analysis study.
    García-Bonafé M; Moragas A
    Anal Cell Pathol; 1996 Nov; 12(2):85-98. PubMed ID: 8986293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of malignant mesothelioma.
    Van Marck E
    Lung Cancer; 2004 Aug; 45 Suppl 1():S35-6. PubMed ID: 15261431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign and malignant mesothelial lesions of the pleura: quantitative study.
    Ranaldi R; Marinelli F; Barbatelli G; Mariuzzi G; Marzocchi F; Mancini AM; Pisani E; Ansuini G; Ricci M
    Appl Pathol; 1986; 4(1-2):55-64. PubMed ID: 3580194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computerized interactive morphometry. A study of malignant mesothelioma and mesothelial hyperplasia in pleural biopsy specimens.
    Marchevsky AM; Gil J; Caccamo D
    Arch Pathol Lab Med; 1985 Dec; 109(12):1102-5. PubMed ID: 3840984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manganese superoxide dismutase as a diagnostic marker for malignant pleural mesothelioma.
    Kahlos K; Pääkkö P; Kurttila E; Soini Y; Kinnula VL
    Br J Cancer; 2000 Mar; 82(5):1022-9. PubMed ID: 10737384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant mesothelioma in Basse-Normandie, a French population study. Descriptive analysis, prognostic factors and survival].
    Desoubeaux N; Bouvier V; Gervais R; Galateau-Salle F; Thibon P; Leplumey T; Herbert C; Lecherbonnier Y; Daviet JP; Letourneux M
    Rev Epidemiol Sante Publique; 2001 Dec; 49(6):523-9. PubMed ID: 11845101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
    Kobashi Y; Matsushima T; Irei T
    Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination between benign and malignant prostate tissue using chromatin texture analysis in 3-D by confocal laser scanning microscopy.
    Huisman A; Ploeger LS; Dullens HF; Jonges TN; Belien JA; Meijer GA; Poulin N; Grizzle WE; van Diest PJ
    Prostate; 2007 Feb; 67(3):248-54. PubMed ID: 17075809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital image analysis in cytological diagnosis: a morphometric analysis on pleural mesotheliomas.
    Christen H; Oberholzer M; Buser M; Lötscher R; Gschwind R; Rösel F; Ettlin R; Feess A; Dalquen P
    Anal Cell Pathol; 1989 Apr; 1(2):105-22. PubMed ID: 2487514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pleuromesothelioma -- psychology and pathogenesis].
    Müller KM
    Pneumologie; 2004 Sep; 58(9):670-9. PubMed ID: 15343490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of underlying characteristics of nuclear chromatin patterns of thyroid tumor cells using texture and factor analyses.
    Murata S; Mochizuki K; Nakazawa T; Kondo T; Nakamura N; Yamashita H; Urata Y; Ashihara T; Katoh R
    Cytometry; 2002 Nov; 49(3):91-5. PubMed ID: 12442308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative ultrastructural study of nuclei from exfoliated benign and malignant mesothelial cells and metastatic adenocarcinoma cells.
    Dardick I; Butler EB; Dardick AM
    Acta Cytol; 1986; 30(4):379-84. PubMed ID: 3461648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.